SSEK Law Firm

The projects and natural resources team at SSEK Law Firm boasts ‘a deep understanding of the Indonesian regulatory landscape’, which is utilised in the assistance it provides to renewable energy providers, investors and corporations across multiple jurisdictions. Michael Twomey has a background in project finance but is equipped to advise on production sharing contracts (PSC) and administrative document replacement certificates. He leads the team alongside Fitriana Mahiddin, who is hailed by clients as ’an absolute pleasure to work with’. Mahiddin is prepared to handle corporate restructurings, infrastructure acquisitions and renewable energy product development matters.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

'Fitriana Mahiddin is an absolute pleasure to work with. She is dedicated and manages a large and coordinated team of first class lawyers. She provides practical advice that is easy to understand.'
'The SSEK team have a deep understanding of the Indonesian regulatory landscape and, most importantly, the working policy and positions of the regulatory bodies. This is critical given the broad nature of Indonesian laws and regulations. SSEK\'s ability to obtain accurate insights directly from policy implementers is unparallelled.'

Key clients

Genting Energy
Energy Development Corporation
Pertamina
McDermott
TotalEnergies Renewables

Work highlights

Assisted with the framework agreement for a major state-backed collaboration to establish one of Indonesia’s largest bioethanol plants, supporting national biofuel goals, energy transition, and SOE ecosystem development.

Advised on the localization of a complex regional power distribution agreement for distributed solar generation in Indonesia, enabling scalable and compliant deployment amid the country’s evolving regulatory landscape and clean energy goals.

Acted as Indonesian counsel for a major investment to establish Southeast Asia’s largest plasma fractionation facility, a strategic healthcare project aimed at reducing Indonesia’s reliance on imported plasma-derived medicines.